Financhill
Back

GSK PLC 10K Form

Sell
30

GSK
GSK PLC

Last Price:
39.61
Seasonality Move:
1.52%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive GSK News And Ratings

See the #1 stock for the next 7 days that we like better than GSK

GSK Financial Statistics

Sales & Book Value

Annual Sales: $37.74B
Cash Flow: $2.96B
Price / Cash Flow: 15.55
Annual Sales: $8.38
Price / Book: 4.72

Profitability

EPS (TTM): 2.79510
Net Income (TTM): $6.13B
Gross Margin: $27.08B
Return on Equity: 41.85%
Return on Assets: 8.29%

GSK PLC Earnings Forecast

Key GSK PLC Financial Ratios

  • The Gross Profit Margin over the past 29 years for GSK is 71.76%.
  • The Selling, General & Administrative Expenses for GSK have been equal to 30.95% of Gross Profit Margin.
  • The Research & Development expenses have been 20.52% of Revenue.
  • The Interest Expense is 14.71% of Operating Income.
  • The Net Earning history of GSK is 16.25% of Total Revenues.
  • Per Share Earnings over the last 38 years have been positive in 23 years.

GSK PLC Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NYSE
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: GSK
CUSIP: 37733W
Website: gsk.com

Debt

Debt-to-Equity Ratio: 1.26
Current Ratio: 0.88
Quick Ratio: 0.59

Price-to-Earnings

Trailing P/E Ratio: 13.16
Forward P/E Ratio: 8.68

GSK Technical Analysis vs Fundamental Analysis

Sell
30
GSK PLC (GSK) is a Sell

Is GSK PLC a Buy or a Sell?

  • GSK PLC stock is rated a Sell
    The current GSK PLC [GSK] share price is $39.27. The Score for GSK is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.